Expected benefits (95 percent credibility intervals) when preventing LA-MRSA from being introduced into the Swedish pig population assuming human prevalence as in, respectively, Denmark and the Netherlands (€, 2011 prices).
收藏NIAID Data Ecosystem2026-03-08 收录
数据链接：
官方服务：
资源简介：
a Prevalence independent Expected benefits (95 percent credibility intervals) when preventing LA-MRSA from being introduced into the Swedish pig population assuming human prevalence as in, respectively, Denmark and the Netherlands (€, 2011 prices).
创建时间：
2015-04-29
